These results are based on the in silico docking study against different COVID-19 Proteins. The lowest Dock Score represents better binding to the specific receptor(protein) molecule.
Sr No | Ligand | Target | Binding Energy |
Docking Rank![]() |
Generic Name | Type | Name of Target | Name of Plant | Edit | Docking Score (General) |
---|---|---|---|---|---|---|---|---|---|---|
91 | DB00483 | 6nur | -1.10 | Gallamine triethiodide | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 91 | |||
92 | DB00362 | qhd43415_1 | -6.30 | Anidulafungin | Ligand | Host translation inhibitor nsp1 | 92 | |||
93 | DB00007 | 6lu7 | -8.20 | Leuprolide | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 93 | |||
94 | DB00520 | qhd43415_1 | -5.90 | Caspofungin | Ligand | Host translation inhibitor nsp1 | 94 | |||
95 | DB00314 | 6nur | -8.40 | Capreomycin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 95 | |||
96 | DB00200 | qhd43415_1 | -6.40 | Hydroxocobalamin | Ligand | Host translation inhibitor nsp1 | 96 | |||
97 | DB00512 | 6nur | -9.60 | Vancomycin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 97 | |||
98 | DB00337 | qhd43415_1 | -5.80 | Pimecrolimus | Ligand | Host translation inhibitor nsp1 | 98 | |||
99 | DB00200 | 6nur | -8.80 | Hydroxocobalamin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 99 | |||
100 | DB00007 | qhd43415_10 | -7.60 | Leuprolide | Ligand | Non-structural protein 10 (nsp10) | 100 | |||
101 | DB00541 | qhd43415_1 | -5.80 | Vincristine | Ligand | Host translation inhibitor nsp1 | 101 | |||
102 | DB00091 | 6lu7 | -5.60 | Cyclosporine | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 102 | |||
103 | DB00104 | qhd43415_1 | -5.40 | Octreotide | Ligand | Host translation inhibitor nsp1 | 103 | |||
104 | DB00541 | qhd43415_10 | -7.40 | Vincristine | Ligand | Non-structural protein 10 (nsp10) | 104 | |||
105 | DB00106 | 6lu7 | -6.70 | Abarelix | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 105 | |||
106 | DB00035 | 6nur | -9.10 | Desmopressin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 106 | |||
107 | DB00416 | 6lu7 | -0.90 | Metocurine iodide | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 107 | |||
108 | DB00403 | 6vsb | -6.90 | Ceruletide | Ligand | Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | 108 | |||
109 | DB00337 | qhd43415_10 | -7.90 | Pimecrolimus | Ligand | Non-structural protein 10 (nsp10) | 109 | |||
110 | DB00027 | qhd43415_1 | -5.90 | Gramicidin D | Ligand | Host translation inhibitor nsp1 | 110 | |||
111 | DB00014 | 6nur | -9.30 | Goserelin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 111 | |||
112 | DB00364 | 6lu7 | -1.80 | Sucralfate | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 112 | |||
113 | DB00007 | 6vsb | -6.60 | Leuprolide | Ligand | Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | 113 | |||
114 | DB00014 | qhd43415_10 | -7.10 | Goserelin | Ligand | Non-structural protein 10 (nsp10) | 114 | |||
115 | DB00050 | 6nur | -8.40 | Cetrorelix | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 115 | |||
116 | DB00104 | 6nur | -8.80 | Octreotide | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 116 | |||
117 | DB00290 | qhd43415_1 | -6.50 | Bleomycin | Ligand | Host translation inhibitor nsp1 | 117 | |||
118 | DB00337 | 6lu7 | -6.80 | Pimecrolimus | Ligand | The crystal structure of COVID-19 main protease in complex with an inhibitor N3 | 118 | |||
119 | DB00403 | 6nur | -8.10 | Ceruletide | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 119 | |||
120 | DB00511 | 6nur | -9.40 | Acetyldigitoxin | Ligand | SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors | 120 |